TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
3,956
|
3,713
|
2,142 |
| Financial expenses |
0
|
2
|
2 |
| Earnings before taxes |
-4,933
|
-4,016
|
-916 |
| EBITDA |
-5,023
|
-4,100
|
-893 |
| Total assets |
5,601
|
8,232
|
11,818 |
| Current assets |
5,377
|
8,014
|
11,644 |
| Current liabilities |
1,633
|
2,150
|
1,208 |
| Equity capital |
3,968
|
6,083
|
10,610 |
| - share capital |
351
|
316
|
341 |
| Employees (average) |
39
|
43
|
32 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
70.8%
|
73.9%
|
89.8% |
| Turnover per employee |
101
|
86
|
67 |
| Profit as a percentage of turnover |
-124.7%
|
-108.2%
|
-42.8% |
| Return on assets (ROA) |
-88.1%
|
-48.8%
|
-7.7% |
| Current ratio |
329.3%
|
372.7%
|
963.9% |
| Return on equity (ROE) |
-124.3%
|
-66.0%
|
-8.6% |
| Change turnover |
232
|
1,744
|
1,435 |
| Change turnover % |
6%
|
89%
|
203% |
| Chg. No. of employees |
-4
|
11
|
1 |
| Chg. No. of employees % |
-9%
|
34%
|
3% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.